A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis.
The American journal of gastroenterology（2022）
摘要
HTD1801 is associated with significant improvement in ALP and warrants further study as a treatment for PSC.
更多查看译文
关键词
berberine ursodeoxycholate,cholangitis,dose-finding,proof-of-concept
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要